INCIDENCES OF CANDIDA ALBICANS AND NON-ALBICANS AMONG CATHETER-ASSOCIATED URINARY TRACT INFECTION PATIENTS OF AKOLA CITY
DOI:
https://doi.org/10.22159/ajpcr.2017.v10i11.19769Keywords:
Candida spp, Catheter-associated urinary tract infectionAbstract
Objective: Candida spp. is the third leading cause of catheter-related infections. Candida species is a part of human microflora and it becomes pathogenic when certain conditions are present and cause an opportunistic infections. The present study was undertaken to determine incidences of Candida albicans and non-albicans among catheterized urinary tract infection (UTI) patients of Akola city.
Methods: A total 60 catheter urine samples were collected from patient of all the age group and both sex who had indwelling urinary catheter. The collected catheterized urine samples of patients from various hospitals of Akola city were used for isolation using HiCrome Candida differential agar.
Results: It was found that highest frequency of isolation of Candida spp. was from age group 61-70 years. The predominance of male candidate was more than female having Candida spp. in catheter-associated UTI (C-UTI). Among the Candida spp. C. albicans (64.81%) was predominant over non-albicans spp. while in non-albicans Candida krusei and Candida glabrata were predominant showing 11.11% incidences. It was followed by Candida tropicalis (9.2%) and Candida parapsilosis (3.7%).
Conclusion: The incidences of C. albicans and non-albicans were high among catheter-associated UTI patients.
Downloads
References
Ryan KJ, Ray CG. Sherris Medical Microbiology, An Introduction to Infectious Disease. 4th ed. New York: McGraw-Hill, - McGraw Hill Professional; 2004. p. 661-3.
Al-Oebady MA. Isolation and identification of Candida species from vaginal, urine and oral swabs by chromagar Candida. Int J Adv Res 2015;3(1):948-56.
Emilio B, Jesus G, Maria G. The role of antifungals against Candida biofilm in catheter-releted Candidemia. J Antibiot 2015;4:1-17.
Goyal RK, Sami H, Mishra V, Bareja R, Behara R. Non-albicans candiduria: An emerging threat. J Appl Pharm Sci 2016;6(3):048-50.
Rajeswari P, Vijayalakshmi P, Jegadeeshkumar D. Prevalence of biofilm producing MDR Candida albicans and non - Candida albicans isolate from medical device. Int J Appl Biol Pharm Technol 2012;3(4):254-63.
Akortha EE, Nwaugo VO, Chikwe NO. Antifungal resistance among Candida species from patients with genitourinary tract infection isolated in Benin City, Edo state, Nigeria. Afr J Microbiol Res 2009;3(11):694-9.
Okungbowa FI, Isikhuemhen OS, Dede AP. The distribution frequency of Candida species in the genitourinary tract among symptomatic individuals in Nigerian cities. Rev Iberoam Micol 2003;20(2):60-3.
Bukhary ZA. Candiduria: A review of clinical significance and management. Saudi J Kidney Dis Transpl 2008;19(3):350-60.
Ponmudi R, Uma C, Sivagurunathan P, Aruljothi S. Occurrence and antifungal susceptibility pattern of candiduria isolates among diabetic patients. Int J Pharm Rev Res 2015;5(4):345-9.
Mehta A, Date VS. Determine of incidence of different Candida species in clinical specimens and characterization of Candida species isolates. Indian J Microbiol Res 2016;3(4):342-51.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
